Genetic associations between rheumatoid arthritis and specific HLA class II genes provide clues to understanding the molecular basis for disease susceptibility. There is a remarkable structural relationship among different RA susceptibility genes, in which each of the associated class II alleles encodes a sequence of key amino acids termed the """"""""shared epitope."""""""" In this proposal, we outline mechanistic models to account for the shared epitope association with RA, and interpret these models in the context of an HLA-directed pathway for the development of disease. We propose to test specific hypotheses developed from these alternative models, through a series of aims which will characterize the structural basis for TCR recognition of the shared epitope region, identify altered T cell activation resulting from recognition of shared epitope, and investigate and test mechanisms by which the shared epitope may be involved in the generation or modulation of self-recognition during antigen presentation and processing. We propose that the shared epitope association with RA is not solely based on a specific peptide binding motif and peptide determinant selection, but rather is influenced by a strongly biased direct recognition of shared epitope residues by direct T cell contact. The implications for T cell development, selection, and activation will be tested using a combination of human T cell clones and murine transgenic animal models.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR037296-13
Application #
6171729
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Serrate-Sztein, Susana
Project Start
1994-09-25
Project End
2004-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
13
Fiscal Year
2000
Total Cost
$282,670
Indirect Cost
Name
Benaroya Research Institute at Virginia Mason
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98101
Kuipers, H F; Nagy, N; Ruppert, S M et al. (2016) The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice. Clin Exp Immunol 185:372-81
Kuipers, Hedwich F; Rieck, Mary; Gurevich, Irina et al. (2016) Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A 113:1339-44
Nagy, Nadine; Kaber, Gernot; Johnson, Pamela Y et al. (2015) Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. J Clin Invest 125:3928-40
James, Eddie A; Rieck, Mary; Pieper, Jennifer et al. (2014) Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol 66:1712-22
Pieper, J; Johansson, S; Snir, O et al. (2014) Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics. Scand J Immunol 79:149-55
Ruppert, S M; Hawn, T R; Arrigoni, A et al. (2014) Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res 58:186-92
Evanko, Stephen P; Potter-Perigo, Susan; Bollyky, Paul L et al. (2012) Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol 31:90-100
Bollyky, Paul L; Bogdani, Marika; Bollyky, Jennifer B et al. (2012) The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep 12:471-80
Snir, Omri; Rieck, Mary; Gebe, John A et al. (2011) Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum 63:2873-83
Gebe, John A; Falk, Ben; Unrath, Kellee et al. (2007) Autoreactive T cells in a partially humanized murine model of T1D. Ann N Y Acad Sci 1103:69-76

Showing the most recent 10 out of 39 publications